Contrato PFIS 2021. Raquel Herranz
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
INSTITUTO DE SALUD CARLOS III
Resultados del Ensayo Clínico
Exploring Nets as Minimally Invasive Biomarkers in Pediatric Tumors: A Liquid Biopsy Approach
Benavent, N; (...); Cañete, A
Meeting Abstract. 2025
Patients with bladder cancer have an increased NETosis and impaired DNaseI-mediated NET degradation, which can be therapeutically restored in vitro
Herranz, R; (...); Medina, P
Meeting Abstract. 2023
Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker
Article. 10.1016/j.jprot.2024.105357. 2025
Cita
Contrato PFIS 2021. Raquel Herranz. (FI21/00171). INSTITUTO DE SALUD CARLOS III. 2022-2026. IP:PILAR MEDINA BADENES.
Portal de investigación